Versartis Inc (NASDAQ:VSAR)

1.43
Delayed Data
As of May 25
 -0.075 / -5.00%
Today’s Change
1.35
Today|||52-Week Range
22.10
-35.23%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close1.50
Today’s open1.50
Day’s range1.40 - 1.50
Volume351,798
Average volume (3 months)442,256
Market cap$54.1M
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+22.51%
Earnings growth (this year)-68.05%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.94
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp-0.32-0.31%
PRTKParatek Pharmaceutic...-0.10-0.96%
AMPHAmphastar Pharmaceut...-0.56-3.38%
RETAReata Pharmaceutical...-0.38-1.12%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.96
Annual revenue (last year)$40.0M
Annual profit (last year)-$85.0M
Net profit margin-212.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Jay P. Shepard
Chief Medical Officer, Head-Clinical &
Medical
Robert Gut
Corporate headquarters
Menlo Park, California

Forecasts